The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 18.21

Myeloma (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2016
By Race/Ethnicity, Sex and Years Since Diagnosis

Race/Ethnicity Sex Years Since Diagnosis Completee
0 to <5 5 to <10 10 to <15 15 to <20 20 to <24 0 to <24b >=24d
All Races Both Sexes 78,454 32,030 12,390 4,580 1,515 128,969 2,423 131,392
Males 44,371 17,567 6,651 2,646 818 72,052 947 72,999
Females 34,083 14,463 5,740 1,934 697 56,917 1,475 58,392
White Both Sexes 58,668 24,166 9,726 3,553 1,216 97,330 + +
Males 34,273 13,673 5,361 2,174 660 56,140 + +
Females 24,395 10,494 4,366 1,380 556 41,190 + +
Black Both Sexes 16,092 6,595 2,225 772 216 25,900 + +
Males 8,066 3,203 1,002 354 127 12,751 + +
Females 8,027 3,392 1,223 418 90 13,149 + +
Asian/
Pacific
Islander		 Both Sexes 2,202 821 243 129 55 3,450 + +
Males 1,205 447 141 52 17 1,861 + +
Females 998 375 102 77 38 1,589 + +
Hispanic Both Sexes 6,254 2,272 955 421 106 10,008 + +
Males 3,491 1,278 517 242 76 5,603 + +
Females 2,763 995 439 178 30 4,404 + +

Estimated prevalence percent a on January 1, 2016, of the SEER population diagnosed in the previous 24 years
By Age at Prevalence, Race/Ethnicity and Sex

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races Both Sexes 0.0400 - 0.0000 0.0003 0.0026 0.0146 0.0464 0.1106 0.1970 0.1862 0.0337
Males 0.0454 - 0.0000 0.0004 0.0032 0.0167 0.0540 0.1311 0.2459 0.2554 0.0416
Females 0.0348 - 0.0000 0.0003 0.0020 0.0126 0.0391 0.0921 0.1563 0.1437 0.0274
White Both Sexes 0.0386 - 0.0000 0.0004 0.0022 0.0126 0.0408 0.0989 0.1785 0.1734 0.0304
Males 0.0449 - 0.0001 0.0004 0.0028 0.0144 0.0488 0.1203 0.2258 0.2447 0.0383
Females 0.0324 - - 0.0003 0.0017 0.0108 0.0330 0.0790 0.1383 0.1288 0.0239
Black Both Sexes 0.0574 - 0.0001 0.0001 0.0049 0.0307 0.0885 0.2156 0.3846 0.3403 0.0652
Males 0.0589 - - - 0.0059 0.0360 0.0959 0.2386 0.4730 0.4272 0.0766
Females 0.0560 - 0.0003 0.0002 0.0040 0.0260 0.0821 0.1971 0.3231 0.2973 0.0572
Asian/
Pacific
Islander		 Both Sexes 0.0169 - - 0.0003 0.0017 0.0067 0.0221 0.0594 0.1125 0.1085 0.0184
Males 0.0191 - - 0.0004 0.0027 0.0082 0.0259 0.0706 0.1417 0.1314 0.0226
Females 0.0150 - - - 0.0008 0.0054 0.0188 0.0503 0.0891 0.0937 0.0151
Hispanic Both Sexes 0.0175 0.0000 0.0001 0.0005 0.0026 0.0125 0.0377 0.0870 0.1684 0.1325 0.0275
Males 0.0194 - 0.0001 0.0006 0.0030 0.0143 0.0466 0.1013 0.2056 0.1864 0.0338
Females 0.0156 0.0001 - 0.0003 0.0022 0.0106 0.0289 0.0744 0.1399 0.0992 0.0225

Footnotes:

a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2016 US population estimates based on the average of 2015 and 2016 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years.

b Maximum limited-duration prevalence is 24 years for 1992-2016 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing 0 to <24 and >=24.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.